We selected HRAS oncogene because a significant fraction of metastatic breast cancers demonstrate HRAS amplification based on data extracted from metastatic breast cancer sequencing project in cBioportal (Fig. 4A; ref. 13). This evidence concerns the gene HRAS and breast cancer.